CHERISH: Nusinersen May Improve Motor Function in SMA CHERISH: Nusinersen May Improve Motor Function in SMA

The phase 3 CHERISH trial showed that children with SMA receiving nusinersen had greater improvements in overall motor function and upper-limb function than did those receiving a sham procedure.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news